Repaglinide Tablets 2 Mg

Repaglinide Tablets 2 Mg

Repaglinide Tablets 2 Mg is an oral anti-diabetic medication used for the management of type 2 diabetes mellitus. It belongs to the meglitinide class, which stimulates rapid insulin release from the pancreas to control blood sugar levels. This higher strength is prescribed when lower doses are not sufficient for glycemic control. It is particularly effective in managing post-meal blood sugar spikes and is often used along with diet and lifestyle modifications. In treatment plans, lower strengths like Repaglinide Tablets 1 Mg are used initially, while advanced therapies such as Rybelsus 14 Mg – Semaglutide Tablets may be considered for improved diabetes management.

Mechanism of Action

Rapid Insulin Release

Repaglinide stimulates pancreatic beta cells to release insulin quickly in response to meals.

Post-Meal Blood Sugar Control

This helps reduce spikes in blood glucose levels after eating. For clinical insights, refer to American Diabetes Association (ADA) and for safety guidance, consult Mayo Clinic – Repaglinide Information.

Medical Uses

Repaglinide Tablets 2 Mg is used for:

• Type 2 diabetes mellitus
• Postprandial blood sugar control
• Combination therapy with other antidiabetic medications

It is suitable for patients requiring stronger glucose control.

Dosage and Administration

Repaglinide Tablets 2 Mg is typically taken 15–30 minutes before meals, as directed by a healthcare provider. The dose is adjusted based on blood sugar levels and patient response. In clinical practice, Repaglinide Tablets 1 Mg may be used as a starting dose, while Rybelsus 14 Mg – Semaglutide Tablets is used as an alternative for advanced glycemic control.

Clinical Effectiveness

Clinical studies show that repaglinide effectively lowers post-meal blood sugar levels and improves overall glycemic control when used consistently.

Safety and Side Effects

Common Side Effects

• Hypoglycemia (low blood sugar)
• Headache
• Weight gain

Serious Risks

• Severe hypoglycemia
• Allergic reactions (rare)

Regular blood sugar monitoring is recommended. For more details, refer to Mayo Clinic – Repaglinide Information.

Contraindications and Precautions

Repaglinide Tablets 2 Mg should not be used in:

• Type 1 diabetes mellitus
• Diabetic ketoacidosis
• Severe liver disease

Use with caution in elderly patients or those at risk of hypoglycemia.

Drug Interactions

Repaglinide may interact with other medications that affect blood sugar levels, increasing the risk of hypoglycemia. Patients should inform their healthcare provider about all medicines they are taking. For further reading, refer to American Diabetes Association (ADA).

FAQs